Gata1Plt13/Y
BALB/c-Gata1Plt13
|
anemia |
J:113720
|
decreased embryo size |
J:113720
|
embryo tissue necrosis |
J:113720
|
embryonic lethality during organogenesis, incomplete penetrance |
J:113720
|
lethality throughout fetal growth and development, complete penetrance |
J:113720
|
small liver |
J:113720
|
Gata1Plt13/Gata1+
BALB/c-Gata1Plt13
|
abnormal megakaryocyte morphology |
J:113720
|
abnormal megakaryocyte progenitor cell morphology |
J:113720
|
abnormal myelopoiesis |
J:113720
|
abnormal thrombopoiesis |
J:113720
|
enlarged spleen |
J:113720
|
extramedullary hematopoiesis |
J:113720
|
increased megakaryocyte cell number |
J:113720
|
increased spleen weight |
J:113720
|
polyploidy |
J:113720
|
thrombocytopenia |
J:113720
|
Gata1tm1.1Yen/Gata1tm1.1Yen
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N
|
abnormal erythropoiesis |
J:200716
|
decreased erythroid progenitor cell number |
J:200716
|
normal
hematopoietic system phenotype |
J:200716
|
Gata1tm1Mym/Gata1+
involves: 129P2/OlaHsd
|
abnormal erythropoiesis |
J:88685
|
abnormal megakaryocyte morphology |
J:88685
|
abnormal proerythroblast morphology |
J:88685
|
anemia |
J:88685
|
decreased hematocrit |
J:88685
|
decreased spleen red pulp amount |
J:88685
|
decreased spleen white pulp amount |
J:88685
|
decreased survivor rate |
J:88685
|
enlarged spleen |
J:88685
|
extramedullary hematopoiesis |
J:88685
|
pale spleen |
J:88685
|
premature death |
J:88685
|
thrombocytopenia |
J:88685
|
Gata1tm1Mym/Y
involves: 129P2/OlaHsd
|
abnormal iron level |
J:58508
|
Gata1tm1Mym/Y
involves: 129P2/OlaHsd * BALB/c
|
abnormal embryonic erythropoiesis |
J:40321
|
absent vitelline blood vessels |
J:40321
|
anemia |
J:40321
|
decreased embryo size |
J:40321
|
decreased erythroid progenitor cell number |
J:40321
|
embryonic lethality during organogenesis, complete penetrance |
J:40321
|
pale liver |
J:40321
|
pale yolk sac |
J:40321
|
Gata1tm1Mym/Gata1+
involves: 129P2/OlaHsd * BALB/c
|
abnormal erythropoiesis |
J:40321
|
anemia |
J:40321
|
Gata1tm1Mym/Gata1tm1Mym Tg(Gata1)#Mym/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2J
|
normal
hematopoietic system phenotype |
J:158252
|
Gata1tm1Mym/Y Tg(Gata1)#Mym/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2J
|
normal
hematopoietic system phenotype |
J:158252
|
Gata1tm1Mym/Y Tg(Gata1*V205G)1Mym/0
involves: C57BL/6 * DBA/2
|
abnormal bone marrow cell morphology/development |
J:89054
|
abnormal erythrocyte morphology |
J:89054
|
abnormal megakaryocyte differentiation |
J:89054
|
abnormal megakaryocyte morphology |
J:89054
|
abnormal mononuclear cell morphology |
J:89054
|
abnormal platelet morphology |
J:89054
|
abnormal stress erythropoiesis |
J:89054
|
abnormal thrombopoiesis |
J:89054
|
anisocytosis |
J:89054
|
decreased fetal size |
J:89054
|
increased megakaryocyte cell number |
J:89054
|
pallor |
J:89054
|
thrombocytopenia |
J:89054
|
Gata1tm1Phi/Y
involves: 129P2/OlaHsd * C57BL/6 * FVB
|
no abnormal phenotype detected |
J:85598
|
Gata1tm1Phi/Gata1+ Tg(HBB-cre)1Phi/0
involves: FVB
|
abnormal erythropoiesis |
J:98277
|
anemia |
J:98277
|
Gata1tm1Phi/Gata1+ Tg(HBB-cre)1Phi/0 Tg(HBB-Gata1)G4Phi/0
involves: FVB
|
abnormal erythropoiesis |
J:98277
|
anemia |
J:98277
|
lethality throughout fetal growth and development, complete penetrance |
J:98277
|
Gata1tm1Phi/Gata1+ Tg(HBB-Gata1)G4Phi/0
involves: FVB
|
abnormal erythropoiesis |
J:98277
|
Gata1tm1Phi/Gata1tm1Phi
involves: 129P2/OlaHsd * C57BL/6 * FVB
|
no abnormal phenotype detected |
J:85598
|
Gata1tm1Phi/Y Tg(Dhh-cre)1Mejr/0
involves: 129P2/OlaHsd * C57BL/6 * FVB
|
no abnormal phenotype detected |
J:85598
|
Gata1tm1Sho/Gata1+
involves: 129S4/SvJae * C57BL/6
|
anemia |
J:36249
|
decreased eosinophil cell number |
J:88711
|
Gata1tm1Sho/Y
involves: 129S4/SvJae * C57BL/6
|
abnormal erythropoiesis |
J:36249
|
anemia |
J:36249
|
embryonic lethality during organogenesis, complete penetrance |
J:36249
|
Gata1tm1Sho/Gata1tm1Sho Tg(Gata1)#Mym/0
involves: 129S4/SvJae * C57BL/6 * DBA/2J
|
normal
hematopoietic system phenotype |
J:158252
|
Gata1tm1Sho/Y Tg(Gata1)#Mym/0
involves: 129S4/SvJae * C57BL/6 * DBA/2J
|
normal
hematopoietic system phenotype |
J:158252
|
Gata1tm2.1Sho/Y
involves: 129S4/SvJae * C57BL/6
|
abnormal megakaryocyte differentiation |
J:41605
|
abnormal megakaryocyte morphology |
J:41605
|
abnormal megakaryocyte progenitor cell morphology |
J:41605
|
normal
hematopoietic system phenotype |
J:41605
|
increased mean platelet volume |
J:41605
|
increased megakaryocyte cell number |
J:41605
|
thrombocytopenia |
J:41605
|
Gata1tm2.1Sho/Gata1+
involves: 129S4/SvJae * C57BL/6
|
abnormal megakaryocyte differentiation |
J:41605
|
abnormal megakaryocyte progenitor cell morphology |
J:41605
|
increased megakaryocyte cell number |
J:41605
|
Gata1tm2.1Sho/Gata1tm2.1Sho
involves: 129/Sv * 129S4/SvJae
|
abnormal hematopoietic system physiology |
J:106670
|
Gata1tm2.1Yen/Gata1tm2.1Yen
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N
|
normal
hematopoietic system phenotype |
J:200716
|
Gata1tm2Sho/Y
involves: 129S4/SvJae * C57BL/6
|
abnormal megakaryocyte differentiation |
J:41605
|
abnormal megakaryocyte morphology |
J:41605
|
abnormal megakaryocyte progenitor cell morphology |
J:41605
|
anemia |
J:41605
|
decreased survivor rate |
J:41605
|
increased mean platelet volume |
J:41605
|
increased megakaryocyte cell number |
J:41605
|
thrombocytopenia |
J:41605
|
Gata1tm2Sho/Gata1+
involves: 129S4/SvJae * C57BL/6
|
abnormal megakaryocyte differentiation |
J:41605
|
abnormal megakaryocyte progenitor cell morphology |
J:41605
|
increased megakaryocyte cell number |
J:41605
|
Gata1tm2Sho/Y
involves: 129S4/SvJae * C57BL/6 * CD-1
|
abnormal bone marrow morphology |
J:78348,
J:78540
|
abnormal common myeloid progenitor cell morphology |
J:78348,
J:78540
|
abnormal definitive hematopoiesis |
J:78348
|
abnormal erythroid progenitor cell morphology |
J:78348,
J:78540
|
abnormal hematocrit |
J:78540
|
abnormal liver morphology |
J:78348
|
abnormal megakaryocyte progenitor cell morphology |
J:78348
|
abnormal physiological response to xenobiotic |
J:78540
|
abnormal platelet shape |
J:78348,
J:78540
|
abnormal spleen morphology |
J:78348
|
abnormal spleen red pulp morphology |
J:78540
|
anemia |
J:78348
|
decreased bone marrow cell number |
J:78348,
J:78540
|
decreased erythrocyte cell number |
J:78348
|
decreased erythroid progenitor cell number |
J:78540
|
decreased hematocrit |
J:78348
|
decreased lymphocyte cell number |
J:78348
|
enlarged spleen |
J:78348,
J:78540
|
extramedullary hematopoiesis |
J:78540
|
increased bone ossification |
J:78348
|
increased bone trabecula number |
J:78348
|
increased erythroid progenitor cell number |
J:78348,
J:78540
|
increased neutrophil cell number |
J:78348
|
increased number of Howell-Jolly bodies |
J:78348
|
increased splenocyte number |
J:78540
|
myelofibrosis |
J:78348
|
poikilocytosis |
J:78348
|
polychromatophilia |
J:78348
|
postnatal lethality, incomplete penetrance |
J:78348
|
premature death |
J:78348
|
prenatal lethality, incomplete penetrance |
J:78348
|
thrombocytopenia |
J:78348,
J:78540
|
Gata1tm2Sho/Gata1tm2Sho
involves: 129S4/SvJae
|
increased bone ossification |
J:111270
|
increased compact bone volume |
J:111270
|
increased osteoblast cell number |
J:111270
|
increased osteoclast cell number |
J:111270
|
increased trabecular bone volume |
J:111270
|
Gata1tm2Sho/Gata1tm2Sho
involves: 129S4/SvJae * C57BL/6 * CD-1
|
abnormal bone marrow morphology |
J:78348,
J:78540
|
abnormal common myeloid progenitor cell morphology |
J:78348,
J:78540
|
abnormal definitive hematopoiesis |
J:78348
|
abnormal erythroid progenitor cell morphology |
J:78348,
J:78540
|
abnormal hematocrit |
J:78540
|
abnormal liver morphology |
J:78348
|
abnormal megakaryocyte progenitor cell morphology |
J:78348
|
abnormal physiological response to xenobiotic |
J:78540
|
abnormal platelet shape |
J:78348,
J:78540
|
abnormal spleen morphology |
J:78348
|
abnormal spleen red pulp morphology |
J:78540
|
anemia |
J:78348
|
decreased bone marrow cell number |
J:78348,
J:78540
|
decreased erythrocyte cell number |
J:78348
|
decreased erythroid progenitor cell number |
J:78540
|
decreased hematocrit |
J:78348
|
decreased lymphocyte cell number |
J:78348
|
enlarged spleen |
J:78348,
J:78540
|
extramedullary hematopoiesis |
J:78540
|
increased bone ossification |
J:78348
|
increased bone trabecula number |
J:78348
|
increased erythroid progenitor cell number |
J:78348,
J:78540
|
increased neutrophil cell number |
J:78348
|
increased number of Howell-Jolly bodies |
J:78348
|
increased splenocyte number |
J:78540
|
myelofibrosis |
J:78348
|
poikilocytosis |
J:78348
|
polychromatophilia |
J:78348
|
postnatal lethality, incomplete penetrance |
J:78348
|
premature death |
J:78348
|
prenatal lethality, incomplete penetrance |
J:78348
|
thrombocytopenia |
J:78348,
J:78540
|
Gata1tm4Sho/Y
involves: 129S6/SvEvTac * C57BL/6
|
abnormal erythropoiesis |
J:77724
|
abnormal megakaryocyte differentiation |
J:77724
|
abnormal megakaryocyte progenitor cell morphology |
J:77724
|
anemia |
J:77724
|
embryonic lethality during organogenesis, incomplete penetrance |
J:77724
|
neonatal lethality, complete penetrance |
J:77724
|
Gata1tm5(GATA3)Sho/Y
involves: 129S4/SvJae * C57BL/6
|
abnormal erythropoiesis |
J:47295
|
anemia |
J:47295
|
decreased embryo size |
J:47295
|
embryonic lethality during organogenesis, complete penetrance |
J:47295
|
enlarged pericardium |
J:47295
|
pale yolk sac |
J:47295
|
pallor |
J:47295
|
Gata1tm5(GATA3)Sho/Gata1+
involves: 129S4/SvJae * C57BL/6
|
abnormal definitive hematopoiesis |
J:47295
|
anemia |
J:47295
|
decreased erythrocyte cell number |
J:47295
|
decreased survivor rate |
J:47295
|
embryonic lethality during organogenesis, incomplete penetrance |
J:47295
|
lethality throughout fetal growth and development, incomplete penetrance |
J:47295
|
pale yolk sac |
J:47295
|
pallor |
J:47295
|
Gata1tm6Sho/Y
involves: 129S1/Sv
|
decreased eosinophil cell number |
J:88711
|
decreased erythrocyte cell number |
J:88711
|
decreased hematocrit |
J:88711
|
enlarged spleen |
J:88711
|
normal
hematopoietic system phenotype |
J:88711
|
Gata1tm6Sho/Gata1tm6Sho
C.129S1-Gata1tm6Sho
|
abnormal skin physiology |
J:182213
|
autoimmune response |
J:182213
|
Gata1tm6Sho/Gata1tm6Sho
involves: 129S1/Sv
|
decreased eosinophil cell number |
J:88711
|
normal
hematopoietic system phenotype |
J:88711
|
Gata1tm6Sho/Gata1tm6Sho
involves: 129S1/Sv * BALB/c
|
abnormal bronchiole morphology |
J:92849
|
abnormal hemostasis |
J:115273
|
abnormal leukocyte cell number |
J:115273
|
abnormal respiratory system physiology |
J:92849
|
decreased circulating interleukin-4 level |
J:115273
|
decreased circulating interleukin-13 level |
J:115273
|
decreased eosinophil cell number |
J:115273
|
decreased lymphocyte cell number |
J:115273
|
increased neutrophil cell number |
J:115273
|
normal
respiratory system phenotype |
J:92849
|
Gata1tm7Sho/Y
involves: 129S1/Sv * C57BL/6
|
abnormal erythropoiesis |
J:99310
|
abnormal megakaryocyte progenitor cell morphology |
J:99310
|
liver hypoplasia |
J:99310
|
pale liver |
J:99310
|
Gata1tm7Sho/Gata1tm7Sho
involves: 129S1/Sv * C57BL/6
|
abnormal erythropoiesis |
J:99310
|
abnormal megakaryocyte progenitor cell morphology |
J:99310
|
liver hypoplasia |
J:99310
|
pale liver |
J:99310
|
Gata1tm8.1Sho/Y
involves: 129S1/Sv * C57BL/6
|
abnormal megakaryocyte morphology |
J:99310
|
Gata1tm8.1Sho/Gata1tm8.1Sho
involves: 129S1/Sv * C57BL/6
|
abnormal megakaryocyte morphology |
J:99310
|
Gata1tm8.2Sho/Y
involves: 129S1/Sv
|
abnormal erythropoiesis |
J:99310
|
abnormal megakaryocyte morphology |
J:99310
|
liver hypoplasia |
J:99310
|
pale liver |
J:99310
|
Gata1tm8.2Sho/Gata1tm8.2Sho
involves: 129S1/Sv
|
abnormal erythropoiesis |
J:99310
|
abnormal megakaryocyte morphology |
J:99310
|
liver hypoplasia |
J:99310
|
pale liver |
J:99310
|
Gata1tm9Sho/Y
involves: C57BL/6
|
normal
hematopoietic system phenotype |
J:132560
|
Gata1tm9Sho/Y
Not Specified
|
impaired hematopoiesis |
J:100411
|
Gata1tm10Sho/Y
involves: C57BL/6
|
decreased erythroid progenitor cell number |
J:132560
|
normal
hematopoietic system phenotype |
J:132560
|
Tg(HBB-Gata1)G4Phi/Y
involves: 129P2/OlaHsd * FVB
|
abnormal erythropoiesis |
J:63773
|
anemia |
J:63773
|
lethality throughout fetal growth and development, incomplete penetrance |
J:63773
|
Tg(HBB-Gata1)G4Phi/0
involves: 129P2/OlaHsd * FVB
|
no abnormal phenotype detected |
J:63773
|
Tg(HBB-Gata1)G4Phi/Y
involves: FVB
|
abnormal erythropoiesis |
J:98277
|
anemia |
J:98277
|
lethality throughout fetal growth and development, incomplete penetrance |
J:98277
|